Bio Key International Inc (BKYI) Financial Statements
Industry: Prepackaged Software (Services)
In fiscal 2025, Bio Key International reported revenue of $5.9M, down 14.3% from $6.9M the year before. Net income was -$7.2M (a -120.6% net margin). Gross margin was 76.9% and operating margin was -115.0%. Operating activities generated -$4.7M of cash, leaving -$4.7M of free cash flow. At fiscal year end, Bio Key International held $8.3M in total assets against $3.2M in total liabilities, including $2.7M of cash and equivalents.
Open the full interactive Bio Key International financials → Quarterly statements, key ratios, valuation history and price charts.
Bio Key International Key Stats
| Share Price | $2.83 |
|---|---|
| Market Cap | $2.9M |
| Revenue YoY Growth | -14.3% |
| 52-Week Range | $1.65 – $10.30 |
| Shares Outstanding | 1.0 million (basic, 2026 Q2) |
Bio Key International Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8M | $5.1M | $7.0M | $7.8M | $6.9M | $5.9M |
| Cost of Goods Sold | $794,826 | $1.7M | $2.4M | $6.3M | $1.3M | $1.4M |
| Gross Profit | $2.0M | $3.4M | $4.6M | $1.4M | $5.6M | $4.6M |
| Operating Income | -$4.5M | -$4.9M | -$9.9M | -$8.8M | -$4.0M | -$6.8M |
| Pre-Tax Income | -$9.7M | -$5.1M | -$11.9M | -$8.7M | -$4.3M | -$7.1M |
| Income Tax | $0 | $0 | $20,434 | -$134,014 | -$22,998 | $16,500 |
| Net Income | -$9.7M | -$5.1M | -$11.9M | -$8.5M | -$4.3M | -$7.2M |
| Diluted EPS | -$374.40 | -$117.00 | — | — | — | — |
Bio Key International Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.5M | $1.1M | $2.1M | $1.9M |
| Net Income | -$964,849 | -$4.3M | -$205,037 | -$576,852 |
Bio Key International Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.0M | $7.8M | $2.6M | $511,400 | $437,604 | $2.7M |
| Current Assets | $18.9M | $14.0M | $9.0M | $2.6M | $1.9M | $4.5M |
| Total Assets | $22.5M | $17.8M | $11.3M | $4.5M | $8.6M | $8.3M |
| Current Liabilities | $1.9M | $2.0M | $5.5M | $3.2M | $4.6M | $3.1M |
| Total Long-Term Debt | — | — | $446,767 | $327,517 | $44,762 | — |
| Total Liabilities | $2.2M | $2.2M | $6.0M | $3.5M | $4.8M | $3.2M |
| Shareholders' Equity | $20.3M | $15.6M | $5.3M | $1.1M | $3.8M | $5.1M |
Bio Key International Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$5.0M | -$9.0M | -$6.2M | -$3.8M | -$2.9M | -$4.7M |
| Cash From Investing | -$2.2M | -$42,024 | -$696,618 | -$1,000 | -$13,047 | -$12,012 |
| Cash From Financing | $24.1M | -$218,598 | $1.9M | $1.4M | $2.8M | $6.9M |
| Free Cash Flow | -$5.0M | -$9.0M | -$6.3M | -$3.8M | -$2.9M | -$4.7M |
Figures from Bio Key International's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Bio Key International financials page for every line item.
Bio Key International Company Profile
| Ticker | BKYI |
|---|---|
| Exchange | Nasdaq |
| Industry | Prepackaged Software (Services) |
| Headquarters | Holmdel, New Jersey |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001019034 |
Frequently Asked Questions
What was Bio Key International's revenue in fiscal 2025?
Bio Key International (BKYI) reported revenue of $5.9M for fiscal 2025.
What is Bio Key International's annual revenue history?
Bio Key International's annual revenue by fiscal year: 2020: $2.8M; 2021: $5.1M; 2022: $7.0M; 2023: $7.8M; 2024: $6.9M; 2025: $5.9M.
What was Bio Key International's net income in fiscal 2025?
Bio Key International reported net income of -$7.2M for fiscal 2025.
How much free cash flow did Bio Key International generate in fiscal 2025?
Bio Key International generated -$4.7M of free cash flow in fiscal 2025.
What was Bio Key International's revenue last quarter?
In its most recent reported quarter (2026 Q2), Bio Key International reported revenue of $1.9M.
How many shares of Bio Key International are outstanding?
Bio Key International reported a weighted average of 1.0 million basic shares outstanding in 2026 Q2.
What is Bio Key International's market cap?
Based on its latest closing price, Bio Key International (BKYI) has a market capitalization of about $2.9M.
When does Bio Key International's fiscal year end?
Bio Key International's fiscal year end, as registered with the SEC, is December 31.
Where is Bio Key International headquartered?
Bio Key International lists its business address in Holmdel, New Jersey in its SEC filings.